Skip to content
Catalyst

PapersPMID:24819981

Resveratrol levels and all-cause mortality in older community-dwelling adults.

JAMA internal medicine2014The record ↗

  1. Finding, moderate evidenceno difference foundAll-cause mortality

No finding here moved its endpoint.

What did not

1 findingHow to read these marks →
  • No detected effect on all-cause mortality

    moderate

    “Total urinary resveratrol metabolites concentration was not significantly associated with mortality in models adjusting for age, sex, BMI, serum levels of lipids, chronic diseases, and other variables.”
    Study
    cohort
    Duration
    9 years
    Dose studied
    no dose given; exposure is quartile of baseline 24-h urinary total resveratrol metabolites (LC-MS/MS, per g creatinine)
    Population
    Community-dwelling men and women aged 65 years and older in the InCHIANTI Study, Tuscany, with 24-hour urine at baseline; exposure is dietary resveratrol, not a dose given

Study record

Design
cohort study
Species
human
Population
community-dwelling men and women aged 65 years and older, InCHIANTI Study, Tuscany, Italy; exposure is dietary resveratrol and 24-h urinary resveratrol metabolites, not a dosed intervention
Participants
783
Comparator
observational
Duration
3,287 days
Endpoints measured
27